Shuttle Pharmaceuticals Holdings, Inc.

SHPH
$4.02 (+ $0.24 + 6.35%)
Last updated: 2026-06-28 03:57 UTC
SHPH Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS8256934014
CUSIP825693401
Market Price4.02
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-3.42
Market Cap$2.9M
Book Value1.13
Price to Book1.596
Beta0.56
52w High25.25
52w Low1.26
Next Earnings DateN/A

Shuttle Pharmaceuticals Holdings, Inc. trades under ticker SHPH on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US8256934014, CUSIP 825693401.

About the Company
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Price History